Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation
- 14 December 2015
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 112 (52) , E7230-E7238
Abstract
Significance: The activated B cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) has a poor clinical outcome and is characterized by constitutive caspase recruitment domain-containing protein 11 (CARD11)/B-cell CLL/lymphoma 10 (BCL10)/mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1) signaling and nuclear factor kappa-B (NF-κB) activation, which is essential for tumor cell survival. However, NF-κB inhibitors have not reached the clinic due to high toxicity, and alternative strategies for targeted therapies are needed. Using mouse genetics, we demonstrate that forced CARD11/BCL10/MALT1 signaling drives lethal lymphoproliferation through simultaneous NF-κB and c-Jun N-terminal kinase (JNK) activation. Pharmacological inhibition of JNK was similar to NF-κB blockage and toxic to autonomously proliferating murine B cells, and constitutive JNK activity was observed in human ABC-DLBCL cells, which are also sensitive to JNK inhibitors. Our results identify the JNK pathway as a therapeutic target for DLBCL.Keywords
Funding Information
- EC | European Research Council (322865)
- Deutsche Forschungsgemeinschaft (RU 695/6-1)
- Deutsche Forschungsgemeinschaft (SFB 684)
- Deutsche Forschungsgemeinschaft (SFB 1054)
- Helmholtz Association (PCCC)
This publication has 52 references indexed in Scilit:
- T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1The EMBO Journal, 2011
- Oncogenic CARD11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory DomainBiochemistry, 2010
- The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphomaJournal of Experimental Medicine, 2010
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaNature, 2010
- Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cellsJournal of Experimental Medicine, 2009
- Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survivalNature, 2008
- The CARMA1-Bcl10 Signaling Complex Selectively Regulates JNK2 Kinase in the T Cell Receptor-Signaling PathwayImmunity, 2007
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000